Knockdown of FOXK1 inhibited the proliferation, migration and invasion in hepatocellular carcinoma cells

Biomedicine and Pharmacotherapy

Volumn 92, Issue , 2017, Pages 270-276

  Li, Peikun ^a   Yu, Zhongshan ^a   He, Liang ^a   Zhou, Dachen ^a   Xie, Shengxue ^a   Hou, Hui ^a   Geng, Xiaoping ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

FOXK1; Hepatocellular carcinoma; Invasion; Proliferation; Wnt catenin pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR FOXK1; UNCLASSIFIED DRUG; FOXK1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DEFICIENCY; GENE KNOCKDOWN; GENETICS; LIVER TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR INVASION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS;

EID: 85019539672     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.05.087     Document Type: Article

References (26)

1. Venook, A.P., Papandreou, C., Furuse, J., Guevara, L.L.D., The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15:Suppl. 4 (2010), 5–13.
2. Sturm, J.W., Keese, M., Multimodal treatment of hepatocellular carcinoma (HCC). Onkologie 27 (2004), 294–303.
3. Barbare, J.C., Bouché, O., Bonnetain, F., Dahan, L., Lombard-Bohas, C., Faroux, R., et al. Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study. Eur. J. Cancer 45 (2009), 1788–1797.
4. Boucher, E., Corbinais, S., Brissot, P., Boudjema, K., Raoul, J.L., Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen). Cancer Chemother. Pharmacol. 50 (2002), 305–308.
5. Yang, W., Yan, K., Goldberg, S.N., Ahmed, M., Lee, J.C., Wu, W., et al. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J. Gastroenterol. 22 (2016), 2993–3005.
6. Liu, W., Wang, K., Bao, Q., Sun, Y., Xing, B.C., Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World J. Surg. Oncol. 14 (2016), 1–8.
7. Hannenhalli, S., Kaestner, K.H., The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 10 (2009), 233–240.
8. Coffer, P.J., Burgering, B.M., Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4 (2004), 889–899.
9. Kuroyanagi, H., Fox-1 family of RNA-binding proteins. Cell. Mol. Life Sci. 66 (2009), 3895–3907.
10. Huang, J.T., Lee, V., Identification and characterization of a novel human FOXK1 gene in silico. Int. J. Oncol. 25 (2004), 751–757.
11. Peng, Y., Zhang, P., Huang, X., Yan, Q., Wu, M., Xie, R., et al. Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells. Cell Death Dis., 7, 2016, e2480.
12. Wu, M., Wang, J., Tang, W., Zhan, X., Li, Y., Peng, Y., et al. FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancer. Oncogenesis, 5, 2016, e271.
13. Sun, T., Wang, H., Li, Q., Qian, Z., Shen, C., Forkhead box protein k1 recruits TET1 to act as a tumor suppressor and is associated with MRI detection. Jpn. J. Clin. Oncol. 46 (2016), 209–221.
14. Xiao, W., He, B., Yong, G., Li, Y., FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma. Tumor Biol. 37 (2016), 10459–10467.
15. Chen, H.W., Huang, X.D., Li, H.C., He, S., Ni, R.Z., Chen, C.H., et al. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients’ prognosis and tumor cell proliferation. Mol. Carcinog. 52 (2013), 647–659.
16. Choi, H.J., Cho, B.C., Sohn, J.H., Shin, S.J., Kim, S.H., Kim, J.H., et al. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J. Neuro-Oncol. 91 (2009), 307–313.
17. Wu, Y., Peng, Y., Wu, M., Zhang, W., Zhang, M., Xie, R., et al. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Oncotarget 7 (2016), 51150–51162.
18. Klaus, A., Birchmeier, W., Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 8 (2008), 387–398.
19. Lin, H.H., Feng, W.C., Lu, L.C., Shao, Y.Y., Hsu, C.H., Cheng, A.L., Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma. Cancer Lett. 381 (2016), 58–66.
20. Vilchez, V., Turcios, L., Marti, F., Gedaly, R., Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World J. Gastroenterol. 22 (2016), 823–832.
21. Clevers, H., Nusse, R., Wnt/β-catenin signaling and disease. Cell 149 (2012), 1192–1205.
22. Yan, J., Yang, Y., Shuang, L., Herman, J.G., Lu, F., Guo, M., SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Epigenetics 5 (2010), 743–749.
23. Wang, Y., Qin, J., Qian, L., Hong, X., Li, T., Zhu, Y., et al. SNF2H promotes hepatocellular carcinoma proliferation by activating the Wnt/β-catenin signaling pathway. Oncol. Lett. 12 (2016), 1329–1336.
24. Yang, T., Cai, S.Y., Zhang, J., Lu, J.H., Lin, C., Zhai, J., et al. Kruppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma. PLoS One, 7, 2012 e39668–e39668.
25. Tsao, C.M., Yan, M.D., Shih, Y.L., Yu PN, Kuo CC, Lin, W.C., et al. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology 56 (2012), 2277–2287.
26. Casas-Tinto, S., Gomez-Velazquez, M., Granadino, B., Fernandez-Funez, P., FoxK mediates TGF-beta signaling during midgut differentiation in flies. J. Cell Biol. 183 (2008), 1049–1060.